Famotidine
- Product NDC
- 27241-249
- 11-digit product format
- 272410249
- Labeler code
- 27241
- Product ID
- 27241-249_041ec6f5-5445-4403-9e76-12c2cda8eea7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Famotidine
- Dosage form
- FOR SUSPENSION
- Route
- ORAL
- Labeler
- Ajanta Pharma USA Inc.
- Application
- ANDA217529
- Marketing category
- ANDA
- Marketing start
- 2022-04-25
- Substance
- FAMOTIDINE
- Active strength
- 40 mg/5mL
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Famotidine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FAMOTIDINE | 40 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 5QZO15J2Z8 |
| Rxcui | 310274 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 27241-249-49 | Famotidine | 50 mL in 1 BOTTLE | FOR SUSPENSION | 50 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 27241-249 | FAMOTIDINE FOR SUSPENSION [AJANTA PHARMA USA INC.] | 1 | Current NDC, 1 package rows | 20230921_a88e7069-230c-4105-ade0-a98968e18671.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 27241-249-49 | 27241024949 | 50 mL in 1 BOTTLE (27241-249-49) | 50 ml | 2022-04-25 | No | No | Current |